| 000 | 01670 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513212607.0 | ||
| 264 | 0 | _c20000713 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a1084-9785 | ||
| 024 | 7 |
_a10.1089/cbr.1999.14.381 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBreitz, H B | |
| 245 | 0 | 0 |
_aRadiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin. _h[electronic resource] |
| 260 |
_bCancer biotherapy & radiopharmaceuticals _cOct 1999 |
||
| 300 |
_a381-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdiagnostic imaging |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacokinetics |
| 650 | 0 | 4 |
_aBiotin _xanalogs & derivatives |
| 650 | 0 | 4 | _aDose-Response Relationship, Radiation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndium Radioisotopes _xpharmacokinetics |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacokinetics |
| 650 | 0 | 4 | _aPhantoms, Imaging |
| 650 | 0 | 4 |
_aRadioimmunotherapy _xmethods |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 |
_aStreptavidin _xpharmacokinetics |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 |
_aYttrium Radioisotopes _xpharmacokinetics |
| 700 | 1 | _aFisher, D R | |
| 700 | 1 | _aGoris, M L | |
| 700 | 1 | _aKnox, S | |
| 700 | 1 | _aRatliff, B | |
| 700 | 1 | _aMurtha, A D | |
| 700 | 1 | _aWeiden, P L | |
| 773 | 0 |
_tCancer biotherapy & radiopharmaceuticals _gvol. 14 _gno. 5 _gp. 381-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/cbr.1999.14.381 _zAvailable from publisher's website |
| 999 |
_c10801423 _d10801423 |
||